Gene-editing therapy lowers harmful blood fats in early study

A one-time infusion of a gene-editing therapy called CTX310 may safely lower cholesterol and triglyceride levels, according to a small preliminary trial. The first-in-human study, published in 2025, included 15 people with uncontrolled LDL cholesterol, triglycerides, or both.